Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ LARS Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA532042
Description
Recommended positive controls: NT2D1, PC-3, U87-MG, SK-N-SH. Predicted reactivity: Mouse (87%), Rat (85%), Bovine (88%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. Alternatively spliced transcript variants of this gene have been found; however, their full-length nature is not known.
Specifications
LARS | |
Polyclonal | |
Unconjugated | |
LARS1 | |
2310045K21Rik; 3110009L02Rik; AW536573; cytoplasmic leucyl-tRNA synthetase; cytosolic leucyl-tRNA synthetase; hr025Cl; HSPC192; ILFS1; KIAA1352; Lars; LARS1; leucine translase; leucine tRNA ligase 1, cytoplasmic; leucine-tRNA ligase; leucine--tRNA ligase, cytoplasmic; Leucyl-tRNA synthetase; leucyl-tRNA synthetase, cytoplasmic; LEURS; LEUS; LFIS; LRS; mKIAA1352; PIG44; proliferation-inducing gene 44; RNTLS | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
51520 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
0.65 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
Q9P2J5 | |
LARS1 | |
Recombinant fragment corresponding to a region within amino acids 906 and 1176 of Human LARS. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction